GRHR Agonist MR-409 Protects β-Cells from Streptozotocin-Induced Diabetes

By
Jamie Kang
-
0
52
Scientists demonstrated the survival mechanism of the growth hormone-releasing hormone (GHRH) agonist MR-409 on human and rodent β-cells and in preclinical models of type 1 diabetes.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
Abstract